SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-17-002703
Filing Date
2017-04-18
Accepted
2017-04-18 17:21:27
Documents
13
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a2231583z20-f.htm 20-F 2034662
2 EX-1.1 a2231583zex-1_1.htm EX-1.1 2083988
3 EX-4.6 a2231583zex-4_6.htm EX-4.6 1186900
4 EX-12.1 a2231583zex-12_1.htm EX-12.1 11037
5 EX-12.2 a2231583zex-12_2.htm EX-12.2 10988
6 EX-13.1 a2231583zex-13_1.htm EX-13.1 6051
7 EX-13.2 a2231583zex-13_2.htm EX-13.2 6067
8 EX-23.1 a2231583zex-23_1.htm EX-23.1 3342
9 G100232LA29I001.GIF g100232la29i001.gif GRAPHIC 86035
10 G100232LA29I002.GIF g100232la29i002.gif GRAPHIC 74252
11 G100232LA29I003.GIF g100232la29i003.gif GRAPHIC 86635
12 G100232LA29I004.GIF g100232la29i004.gif GRAPHIC 33771
13 G100232LA29I005.GIF g100232la29i005.gif GRAPHIC 74974
  Complete submission text file 0001047469-17-002703.txt   5834528
Mailing Address ?STERGADE 24A, 1 COPENHAGEN G7 1100
Business Address ?STERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36686 | Film No.: 17767639
SIC: 2834 Pharmaceutical Preparations